Post Covid Clinical Trial
How This Trial Works
AgelessRx will enroll over 60 people for a 12 week study
Participants will be assigned to a treatment group or a control group
Participant in the treatment group will receive LDN and NAD+ treatment
Ongoing doctor evaluation will be provided to each participant
Surveys at 2, 4, 8, 12 weeks will be conducted to asses fatigue and quality of life
What Participants Will Receive
There are a large number of people who, despite having relatively mild COVID-19 symptoms, do not recover within a couple of weeks.
Lots of people have turned to online support groups and discuss having symptoms for months, and even calling themselves long-haulers. A report from a patient-led investigation in early May 2020 including 640 respondents showed that 90.6% of them had symptoms that lasted over 2 weeks with an average length of 27 days of symptoms.
Next to the common COVID-19 symptoms, reported additional symptoms included fatigue of varying severity, brain fog and concentration problems, insomnia, chills/sweats, and loss of appetite.
Tune in to the below presentation from our Chief Medical Officer and Co-Founder, Dr. Sajad Zalzala, to learn more about Low Dose Naltrexone (LDN) and NAD+ for treatment of patients with post-COVID-19 syndrome.
Largest Long Covid cohort study published
6 months post-hospital, 1400 people:
76% still had > 1 symptom
63% fatigue/muscle weakness
Anxiety, depression common
Sign Up for More Information
If you're interested in learning more about the Post-COVID-19 trial, sign up using the form below.